Atlas Trials

A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

Clinical trial NCT03531060 · COMPLETED

Trial details

NCT number
NCT03531060
Sponsor
Integrative Research Laboratories AB
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2016-11-08
Primary completion
2017-04-12
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.